Brüderkrankenhaus St. Josef Paderborn

Recent papers from Brüderkrankenhaus St. Josef Paderborn

1. Association of the EHRA/HRS/APHRS/LHRS definition of atrial cardiomyopathy with incident atrial fibrillation, heart failure, and strokeEP Europace · 2026
2. Modelling eCPR eligibility after out-of-hospital cardiac arrest: a 10-year retrospective temporospatial analysis from a mixed urban-rural region in GermanyScandinavian Journal of Trauma Resuscitation and Emergency Medicine · 2026
3. Antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation: an individual patient data network meta-analysisEuropean Heart Journal · 2026
4. Simulation of the Effects of Minimum Case Volume Thresholds on the Geographic Accessibility of Inpatient Neurosurgical Facilities in GermanyHealthcare · 2026
5. Proximal Internal Iliac Artery Ligation in Obstetrics and Gynecology: An 11-Year Retrospective Single-Center Experience with No Clinically Detected Ischemic ComplicationsJournal of Clinical Medicine · 2026
6. Diagnostic value of basic and extended procedures in pediatric fever of unknown origin – results of a nation-wide surveillance studyMolecular and Cellular Pediatrics · 2026
7. Primary versus elective percutaneous transluminal angioplasty with stenting for symptomatic intracranial atherosclerotic stenosis: a 18-centre retrospective cohort study using the pEGASUS-HPC stentEuropean Stroke Journal · 2026
8. Real-World Data on the Use of Nivolumab Monotherapy in the Treatment of Advanced Renal Cell Carcinoma After Prior Therapy: Final Results from the Non-Interventional NORA StudyCancers · 2026
9. Interactions of blood biomolecules with early rhythm control in atrial fibrillation patients: Exploratory analysis of the EAST-AFNET 4 Biomolecule StudyEP Europace · 2026
10. Ibrutinib in early stage CLL: Genetic risk factors and treatment outcome in the GCLLSG CLL12 trialBlood · 2026
11. IGLV3‐21 R110 and ibrutinib treatment: Results from the double‐blind, randomized, placebo‐controlled GCLLSG CLL12 trial in early‐stage CLLHemaSphere · 2026
12. Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trialEuropean Heart Journal · 2022
13. Kidney disease increases the risk of cardiovascular events in patients with device-detected atrial fibrillation: NOAH-AFNET 6EP Europace · 2026
14. PARP inhibition with olaparib and talazoparib for HER2-negative advanced breast cancer—Results from the prospective PRAEGNANT registrynpj Breast Cancer · 2026
15. AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2026Breast Care · 2026
16. AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2026.2026
17. Patient characteristics and treatment outcomes in marginal zone lymphoma: results of the prospective German MZL registryLeukemia · 2026
18. Access to Neurosurgery for Patients in Germany—Strategic Considerations Based on Geographic Information MappingClinics and Practice · 2026
19. Patient‐reported outcomes: active surveillance vs radical therapies in low‐risk prostate cancerBJU International · 2026
20. Abstract PS1-12-05: Liquid Biopsy-Based Molecular Profiling Using Guardant360 CDx at Progression on CDK4/6i+ET: Findings from the AGO-B CAPTOR StudyClinical Cancer Research · 2026